SCHEMBL6925864

SCHEMBL6925864

O=S(=O)(Nc1ccccc1Cl)c1ccc2[nH]c(-c3c(F)cccc3F)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
TSHR P16473 3/20 0.50
MAPT P10636 8/20 0.49
TP53 P04637 4/20 0.47
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPK1 P28482 2/20 0.46
PKM P14618 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GRM4 Q14833 1/20 0.45
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45
KDM4E B2RXH2 3/20 0.45
PTK2B Q14289 1/20 0.45
HPGD P15428 2/20 0.44
GAA P10253 2/20 0.44
GLO1 Q04760 1/20 0.42
MMP2 P08253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6925704 0.97 MEN1 (0.49) MEN1KMT2ATSHRMAPTTP53
SCHEMBL6924681 0.89 MEN1 (0.50) MEN1KMT2ATSHRMAPTTP53
SCHEMBL6925861 0.85 GLO1 (0.47) MEN1KMT2ATSHRMAPTTP53
SCHEMBL6925491 0.85 GRM4 (0.51) MEN1KMT2ATSHRMAPTTP53
SCHEMBL6926045 0.84 MAPT (0.67) MEN1KMT2ATSHRMAPTTP53
SCHEMBL6925674 0.83 MAPT (0.49) MEN1KMT2ATSHRMAPTTP53
SCHEMBL6926516 0.83 MEN1 (0.48) MEN1KMT2ATSHRMAPTTP53
SCHEMBL11372467 0.82 MAPT (0.52) MEN1KMT2ATSHRMAPTTP53
SCHEMBL6926782 0.81 MAPT (0.66) MEN1KMT2ATSHRMAPTTP53
SCHEMBL11370588 0.81 MAPT (0.52) MEN1KMT2ATSHRMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184556-A1 SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-07-19 US disclosed
US-20120184556-A1 SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-07-19 US disclosed
WO-2011011722-A1 SUBSTITUTED BENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS VANDERBILT UNIVERSITY (US) 2011-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184556-A1 SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS GRM4, GRIK4, GRIA4 MEN1 4390/4885KMT2A 1413/4885TSHR 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.